{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:16:04Z","timestamp":1761844564262},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.bulcan.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T05:45:08Z","timestamp":1445838308000},"page":"940-945","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prise en charge symptomatique de l\u2019ascite maligne en phase palliative\u00a0: place de la paracent\u00e8se et des diur\u00e9tiques"],"prefix":"10.1016","volume":"102","author":[{"given":"Vincent","family":"Gamblin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlette","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Villet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"El Hajbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2015.09.002_bib0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejca.2005.11.018","article-title":"Malignant ascites: systematic review and guideline for treatment","volume":"42","author":"Becker","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0170","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jamcollsurg.2004.01.035","article-title":"Malignant ascites: past, present, and future","volume":"198","author":"Adam","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5923\/j.cmd.20120202.01","article-title":"Predictors of poor prognosis in patients with malignant ascites: a prospective study","volume":"2","author":"Ayantunde","year":"2012","journal-title":"Clin Med Diagn"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0185","doi-asserted-by":"crossref","first-page":"D17","DOI":"10.1016\/S0399-8320(04)94983-4","article-title":"Prise en charge symptomatique de la carcinose p\u00e9riton\u00e9ale","volume":"28","author":"Denis","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.revmed.2013.12.001","article-title":"L\u2019ascite non li\u00e9e \u00e0 la cirrhose\u00a0: physiopathologie, diagnostic et \u00e9tiologies","volume":"35","author":"Carrier","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-012-0396-6","article-title":"Malignant ascites: pathophysiology and treatment","volume":"18","author":"Cavazzoni","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0200","first-page":"34","article-title":"Traitement palliative de l\u2019ascite maligne","volume":"13","author":"Abdessalem","year":"2014","journal-title":"Med Pal"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0885-3924(98)00037-2","article-title":"A survey of practices in management of malignant ascites","volume":"16","author":"Lee","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0210","first-page":"493","article-title":"Indwelling catheters for the management of malignant ascites","volume":"8","author":"Lee","year":"2000","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0215","first-page":"CD007794","article-title":"Management of drainage for malignant ascites in gynaecological cancer","volume":"20","author":"Keen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0220","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1684\/bdc.2011.1373","article-title":"Physiopathologie et prise en charge des ascites malignes r\u00e9fractaires","volume":"98","author":"Sa\u00e2da","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0225","series-title":"Symptom management in advanced cancer","first-page":"447","author":"Twycross","year":"2009"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bjs.1800830104","article-title":"Malignant ascites","volume":"83","author":"Parsons","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1191\/026921600676345896","article-title":"Paracentesis \u2013 an effective method of symptom control in the palliative care setting?","volume":"14","author":"Mc Namara","year":"2000","journal-title":"Palliat Med"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-230X-14-18","article-title":"Effects of paracentesis on hemodynamic parameters and respiratory function in critically ill patients","volume":"14","author":"Phillip","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0245","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.20317","article-title":"Performance standards for therapeutic abdominal paracentesis","volume":"40","author":"Grabau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0250","first-page":"2324","article-title":"Paracent\u00e8se abdominale","volume":"4","author":"Glauser","year":"2008","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0255","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cgh.2009.05.004","article-title":"Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study","volume":"7","author":"De Gottardi","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0260","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0270","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archinte.1979.03630390087029","article-title":"Abdominal paracentesis of malignant ascites","volume":"139","author":"Fischer","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0320","series-title":"Palliative management of malignant ascites guidance. Northern Health and Social Care Trust","author":"McAuley","year":"2010"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0285","series-title":"Palliative medicine","first-page":"1260","article-title":"Malignant ascites","author":"Demeulenaere","year":"2009"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0290","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0885-3924(94)00129-9","article-title":"Management of symptomatic malignant ascites with diuretics: two case reports and review of the literature","volume":"90","author":"Sharma","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11864-008-0068-y","article-title":"Treatment of malignant ascites","volume":"9","author":"Chung","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0300","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/bjs.1800690802","article-title":"Control of malignant ascites with spironolactone","volume":"69","author":"Greenway","year":"1982","journal-title":"Br J Surg"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0305","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/0016-5085(92)91520-E","article-title":"Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics","volume":"103","author":"Pockros","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0310","first-page":"51","article-title":"Serum\/ascites albumin gradient in differential diagnosis of ascites","volume":"2","author":"Beg","year":"2001","journal-title":"JIACM"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0315","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jpainsymman.2009.10.002","article-title":"Targeting diurectic use for malignant ascites. Two case reports highlighting the value of the serum-ascites albumin gradient in a palliative setting","volume":"39","author":"Husbands","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.bulcan.2015.09.002_bib0160","first-page":"325","article-title":"Recherche et \u00e9valuation en soins palliatifs\u00a0: panorama et r\u00e9flexions","volume":"10","author":"Gamblin","year":"2011","journal-title":"Med Pal"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511500274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511500274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T05:48:44Z","timestamp":1653371324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745511500274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S000745511500274X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.09.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge symptomatique de l\u2019ascite maligne en phase palliative\u00a0: place de la paracent\u00e8se et des diur\u00e9tiques","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}